Previous close | 202.90 |
Open | N/A |
Bid | 0.00 |
Ask | 0.00 |
Strike | 640.00 |
Expiry date | 2026-01-16 |
Day's range | 202.90 - 202.90 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.